Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overview All 13F holders of TPTX Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of TPTX by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−2,491−100.0%	Sold out	Holders
Q2 2022	2,491	$187.0K	<0.1%	−1,191−32.3%	Reduced	Holders
Q1 2022	3,682	$98.0K	<0.1%	+3,682	New	Holders